Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Clasificación en acciones #28846
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Precio por acción
$1.89
Última sincronización: 2022-12-16
Capitalización bursátil
$24.38M
Cambio (1 día)
8.62%
Cambio (1 año)
0.00%
País
US
Comercio Yumanity Therapeutics, Inc. (YMTX)

Categoría

Historial del precio de la acción de Yumanity Therapeutics, Inc. (YMTX)
Precio más alto de cierre: $1.94 el 2022-12-01

Precio más bajo de cierre: $18.35 el 2020-12-01
Historial del precio de la acción de Yumanity Therapeutics, Inc. desde 2020 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2022 -41.89%
2021 -81.82%
2020 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH